Keyphrases
Hypertensive
100%
Heart Failure
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
COX-2 Inhibitors
100%
Celecoxib
47%
Rofecoxib
31%
Failure Cost
26%
Health Care Costs
15%
Rate Ratio
15%
Confidence Interval
10%
Hospitalization
10%
Incidence Rate
10%
Incremental Cost
10%
Hypertensive Patients
10%
Claim Rate
10%
Hypertension
5%
Rehospitalization
5%
High Incidence
5%
Exposure Time
5%
Confounding Factors
5%
Clinical Practice
5%
Adjusted Rates
5%
Patients with Heart Failure
5%
Employers
5%
Diclofenac
5%
Matched Control Group
5%
Patient Time
5%
Naproxen
5%
Excess Incidence
5%
Initial Claim
5%
History of Heart Failure
5%
Nursing and Health Professions
Heart Failure
100%
Nonsteroid Antiinflammatory Agent
100%
Cyclooxygenase 2 Inhibitor
100%
Outpatient
42%
Celecoxib
42%
Rofecoxib
28%
Health Care Cost
14%
Rate Ratio
14%
Confidence Interval
9%
Clinical Practice
4%
Confounding Factor
4%
Motrin
4%
Naproxen
4%
Diclofenac
4%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
COX-2 Inhibitor
100%
Non-Steroidal Anti-Inflammatory Drug
100%
Celecoxib
42%
Rofecoxib
28%
Ibuprofen
4%
Naproxen
4%
Diclofenac
4%